Pooled analysis on the necessity of random 4-quadrant cervical biopsies and endocervical curettage in women with positive screening but negative colposcopy

Shang-Ying Hu, Wen-Hua Zhang, Shu-Min Li, Nan Li, Man-Ni Huang, Qin-Jing Pan, Xun Zhang, Ying Han, Fang-Hui Zhao, Wen Chen, You-Lin Qiao, Shang-Ying Hu, Wen-Hua Zhang, Shu-Min Li, Nan Li, Man-Ni Huang, Qin-Jing Pan, Xun Zhang, Ying Han, Fang-Hui Zhao, Wen Chen, You-Lin Qiao

Abstract

Controversy remains over whether random cervical biopsies and endocervical curettage (ECC) should be used in women with positive screening but negative colposcopy. Our paper aims to determine the indications for random biopsies and ECC among these screened positive women.Three thousand two hundred thirteen women with any positive screening test result but negative colposcopy, who received random 4-quadrant biopsies, were pooled from 17 population-based cervical cancer screening studies done in China from 1999 to 2008. The detection rates of cervical intraepithelial neoplasia grade 2 or worse (CIN2+) and CIN grade 3 or worse (CIN3+) stratified by cytology and high-risk human papillomavirus (HR-HPV) status were assessed, as well as the false negative rates for CIN2+ and CIN3+ by random biopsies without ECC.Compared with women with negative cytology and positive HR-HPV, those with atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion (ASC-US/LSIL) and negative HR-HPV had the equivalent lower risks of CIN2+ and CIN3+, but ascending risks were observed in the groups of ASC-US/LSIL and positive HR-HPV, and atypical glandular cells/atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion/high-grade squamous intraepithelial lesion or worse (AGC/ASC-H/HSIL+). If random biopsies were only taken without ECC, 9.3% of CIN2+ and 18.5% of CIN3+ would have been missed.For women with any positive screening but negative colposcopy, in areas with good cytological infrastructure, it was necessary to perform random biopsies plus ECC on those with cytological ASC-US/LSIL and positive HR-HPV, AGC, ASC-H, or HSIL+. In contrast, those with other results should be followed up.

Conflict of interest statement

The authors report no conflicts of interest.

Figures

Figure 1
Figure 1
Flowchart of study participants. ECC = endocervical curettage, HR-HPV = high-risk human papillomavirus, VIA = visual inspection with acetic acid.

References

    1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon, France: International Agency for Research on Cancer. 2013;Available at: . Accessed on February 5, 2015.
    1. Pretorius RG, Belinson JL, Burchette RJ, et al. Regardless of skill, performing more biopsies increases the sensitivity of colposcopy. J Low Genit Tract Dis 2011;15:180–8.
    1. Belinson JL, Qiao YL, Pretorius RG, et al. Shanxi Province cervical cancer screening study II: self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology. Int J Gynecol Cancer 2003;13:819–26.
    1. Pretorius RG, Belinson JL, Zhang WH, et al. The colposcopic impression. Is it influenced by the colposcopist's knowledge of the findings on the referral Papanicolaou smear? J Reprod Med 2001;46:724–8.
    1. Qiao YL, Zhang WH, Li L. A cross-sectional comparative study of cervical cancer screening methods in Shanxi Province [in Chinese]. Acta Acad Med Sin 2002;24:50–3.
    1. Kong BH, Zheng WX. Several problems on the diagnosis and treatment of cervical cancer and precancerous lesions in China [in Chinese]. Natl Med J China 2010;90:3027–30.
    1. Gage JC, Hanson VW, Abbey K, et al. Number of cervical biopsies and sensitivity of colposcopy. Obstet Gynecol 2006;108:264–72.
    1. Stoler MH, Vichnin MD, Ferenczy A, et al. The accuracy of colposcopic biopsy: Analyses from the placebo arm of the Gardasil clinical trials. Int J Cancer 2011;128:1354–62.
    1. Jeronimo J, Massad LS, Castle PE, et al. Interobserver agreement in the evaluation of digitized cervical images. Obstet Gynecol 2007;110:833–40.
    1. Massad LS, Jeronimo J, Schiffman M. Interobserver agreement in the assessment of components of colposcopic grading. Obstet Gynecol 2008;111:1279–84.
    1. Pretorius RG, Zhang WH, Belinson JL, et al. Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse. Am J Obstet Gynecol 2004;191:430–4.
    1. Belinson J, Qiao YL, Pretorius R, et al. Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. Gynecol Oncol 2001;83:439–44.
    1. Belinson JL, Hu S, Niyazi M, et al. Prevalence of typespecific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self-collected specimens: implications for vaginal self-collection. Int J Cancer 2010;127:1151–7.
    1. Cagle AJ, Hu SY, Sellors JW, et al. Use of an expanded gold standard to estimate the accuracy of colposcopy and visual inspection with acetic acid. Int J Cancer 2010;126:156–61.
    1. Qiao YL, Sellors JW, Eder PS, et al. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol 2008;9:929–36.
    1. Moy L, Zhao F, Li LY, et al. Human papillomavirus testing and cervical cytology in primary screening for cervical cancer among women in rural China: comparison of sensitivity, specifi city, and frequency of referral. Int J Cancer 2010;127:646–56.
    1. Dai M, Bao YP, Li N, et al. Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study. Br J Cancer 2006;95:96–101.
    1. Li N, Shi JF, Franceschi S, et al. Different cervical cancer screening approaches in a Chinese multicentre study. Br J Cancer 2009;100:532–7.
    1. Lin CQ, Chen F, Liu B, et al. A parallel study of careHPV and Hybrid Capture 2 human papillomavirus DNA testing for cervical cancer screening in rural China. J Virol Methods 2014;202:73–8.
    1. Hu SY, Hong Y, Zhao FH, et al. Prevalence of HPV infection and cervical intraepithelial neoplasia and attitudes towards HPV vaccination among Chinese women aged 18-25 in Jiangsu province. Chin J Cancer Res 2011;23:25–32.
    1. Liu CY, Bian ML, Geng L. Clinical trial on evaluation of Hybrid Capture II for human papillomavirus in screening for cervical cancer and cervical intraepithelial neoplasia [in Chinese]. China Cancer 2009;18:1008–11.
    1. Zhao FH, Lin MJ, Chen F, et al. Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China. Lancet Oncol 2010;11:1160–71.
    1. Zhang WH. The Principal Points of Diagnosis and Treatment for Cervical Lesions. 1st ed.Beijing: People's Medical Publishing House; 2006.
    1. Li N, Zhang WH. Diagnosis and treatment of cervical intraepithelial neoplasia [in Chinese]. Pract J Cancer 2001;16:140–3.
    1. Qian M, You ZX, Yao FF, et al. Analysis of missed CIN2+ in CIN1+ diagnosed by colposcopically directed biopsy [in Chinese]. Chin J Clin Obstet Gynecol 2013;14:403–5.
    1. Cheng YF, Wang XY, Lü WG, et al. Cervical intraepithelial neoplasia 2+ in low-grade squamous intraepithelial lesion pathologically diagnosed by colposcopy-assisted biopsy [in Chinese]. Natl Med J China 2010;90:1882–5.
    1. Yang B, Pretorius RG, Belinson JL, et al. False negative colposcopy is associated with thinner cervical intraepithelial neoplasia 2 and 3. Gynecol Oncol 2008;110:32–6.
    1. Chen XD, Shi HY. Morphological observation of cone biopsy and hysterectomy specimens of high-grade cervical intraepithelial neoplasia [in Chinese]. Zhonghua Fu Chan Ke Za Zhi 2008;43:429–32.
    1. Alvarez RD, Wright TC. Optical Detection Group. Effective cervical neoplasia detection with a noveloptical detection system: a randomized trial. Gynecol Oncol 2007;104:281–9.
    1. Pan QJ, Hu SY, Guo HQ, et al. Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China. Gynecol Oncol 2014;133:172–9.
    1. Song Y, Zhao YQ, Zhang X, et al. Random biopsy in colposcopy-negative quadrant is not effective in women with positive colposcopy in practice. Cancer Epidemiol 2015;39:237–41.
    1. Massad LS, Einstein MH, Huh WK, et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol 2013;121:829–46.
    1. Nam K, Chung S, Kwak J, et al. Random biopsy after colposcopy-directed biopsy improves the diagnosis of cervical intraepithelial neoplasiagrade 2 or worse. J Low Genit Tract Dis 2010;14:346–51.
    1. Huh WK, Sideri M, Stoler M, et al. Relevance of random biopsy at the transformation zone when colposcopy is negative. Obstet Gynecol 2014;124:670–8.
    1. Zhang WH. Colposcopic Diagnostic Atlas. Beijing: People's Medical Publishing House; 2012.
    1. Pretorius RG, Belinson JL, Azizi F, et al. Utility of random cervical biopsy and endocervical curettage in a low-risk population. J Low Genit Tract Dis 2012;16:333–8.
    1. Pretorius RG, Belinson JL, Peterson P, et al. Which colposcopies should include endocervical curettage? J Lower Genit Tract Dis 2015;19:278–81.
    1. Cuzick J, Clavel C, Petry KU, et al. Overview of the European and North American studies on HPV testing in primay cervical cancer screening. Int J Cancer 2006;119:1095–101.
    1. Massad LS. Selecting patients for endocervical curettage. J Low Genit Tract Dis 2015;19:271–2.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir